| HOME >> BIOLOGY >> TECHNOLOGY |
Income (loss) from
continuing operations 16,443 (814,261) (243,140) (1,124,296)
DISCONTINUED OPERATIONS:
Gain on sale of net assets
related to discontinued
operations (net of income
tax of $218,060) 1,534,476 - 1,155,973 -
Net Income (loss) $1,550,919 $ (814,261) $912,833 $(1,124,296)
Income (loss) per share
from continuing operations
- basic $ 0.01 $(0.34) $(0.12) $(0.46)
Income per share from
discontinued operations
- basic 0.74 - 0.56 -
Net income (loss) per share
- basic $ 0.75 $(0.34) $ 0.44 $(0.46)
Income (loss) per share from
continuing operations
- diluted $ 0.01 $(0.34) $(0.12) $(0.46)
Income per share from
discontinued operations
- diluted 0.67 - 0.56 -
Net income (loss) per share
- diluted $ 0.68 $(0.34) $ 0.44 $(0.46)
Weighted average number of
shares used to calculate
income (loss) per share
- basic 2,065,425 2,426,167 2,065,425 2,425,183
Weighted average number of
shares used to calculate
income (loss) per share
- diluted 2,296,930 2,426,167 2,065,425 2,425,183
Consolidated Balance Sheets
(UNAUDITED)
June 30, December 31,
ASSETS 2007 2006
CURRENT ASSETS
Cash and cash equivalents $6,803,674 $ 5,335,282
Accounts receivable
'/>"/>
SOURCE Pressure BioSciences, Inc.![]() Copyright©2007 PR Newswire. |